文献速递前列腺增生与排尿功能障碍

前列腺穿刺活检后6周内行钬激光前列腺剜除术安全有效

Holmium Laser Enucleation of Prostate Within 6 Weeks of Transrectal Ultrasound Guided Prostate Biopsy is Safe and Effective.
PubMed 文献 · Urology · 2020-11-21

本研究回顾性分析552例接受HoLEP的患者,其中84例在术前45天内行经直肠超声引导前列腺穿刺活检。结果显示穿刺后6周内行HoLEP的患者剜除效率更高,且围手术期并发症、术后排尿指标及偶发前列腺癌检出率与对照组无显著差异。

要点

  • 穿刺后6周内行HoLEP不增加手术难度或并发症。
  • 穿刺组剜除效率显著高于对照组(P=0.00)。
  • 两组术后排尿功能及偶发癌检出率无差异。

核心结论

  • 经直肠超声引导前列腺穿刺活检后6周内行HoLEP不影响手术难度或治疗结果。

研究设计与样本

  • 回顾性队列研究,纳入552例接受HoLEP的患者,其中84例在术前45天内行前列腺穿刺活检(研究组),其余为对照组。

主要发现

  • 研究组剜除效率高于对照组(P=0.00)。
  • 两组围手术期并发症、术后排尿指标及偶发前列腺癌检出率无显著差异。

临床怎么用

  • 前列腺穿刺活检后6周内可安全实施HoLEP,无需延迟手术。

局限性

  • 回顾性研究设计,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the safety and efficacy of performing Holmium laser enucleation of the prostate (HoLEP) for the treatment of bladder outlet obstruction secondary to an enlarged prostate within 6-weeks of a transrectal ultrasound (TRUS) guided prostate biopsy. MATERIALS AND METHODS: We performed a retrospective review of patients who underwent a HoLEP at our institution, excluding any patients with a confounding urologic history and compared patients who underwent a TRUS-guided 6- or 12-core prostate biopsy, and then underwent a HoLEP within 6 weeks (study group) with all other patients (control group). Our primary outcomes were enucleation efficiency (EE) and perioperative complication rate. Our secondary outcomes included postoperative drop in hemoglobin, duration of catheterization, length of hospital stay, voiding metrics at 1 and 6 months and rate of incidental prostate cancer diagnosed on histopathological examination of prostate specimens after HoLEP. To test for differences between the study and control groups, we performed independent sample t-test (2-tailed) and chi-square tests for quantitative and qualitative variables, respectively. P values of < 0.05 were considered statistically significant. RESULTS: 552 patients met inclusion criteria and 84 patients underwent prostate biopsy within a period of 45 days prior to HoLEP. Enucleation efficiency was higher in the study group (P = 0.00). There was no significant difference between the 2 groups regarding perioperative complications, postoperative voiding outcomes, or rate of incidental prostate cancer detection. CONCLUSIONS: TRUS prostate biopsy performed within 6 weeks of HoLEP does not negatively impact operative difficulty or treatment outcome.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Etafy MH, Katz JE, Gonzalgo MR, et al. Holmium Laser Enucleation of Prostate Within 6 Weeks of Transrectal Ultrasound Guided Prostate Biopsy is Safe and Effective. Urology. 2020. PMID: 33227302. doi:10.1016/j.urology.2020.11.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。